Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03188965
Title First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA | GBR | CAN

Additional content available in CKB BOOST